Global Ophthalmic Drugs Market Size & Outlook

The ophthalmic drugs industry worldwide is expected to reach a projected revenue of US$ 66,064.5 million by 2030. A compound annual growth rate of 8.3% is expected of the worldwide ophthalmic drugs industry from 2024 to 2030.

Revenue, 2023 (US$M)
$37,823.0
Forecast, 2030 (US$M)
$66,064.5
CAGR, 2024 - 2030
8.3%
Report Coverage
Worldwide

Global ophthalmic drugs market highlights

  • The global ophthalmic drugs market generated a revenue of USD 37,823.0 million in 2023 and is expected to reach USD 66,064.5 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 8.3% by 2030.
  • In terms of segment, anti-vegf agents accounted for a revenue of USD 12,370.2 million in 2023.
  • Gene & Cell Therapy is the most lucrative drug class segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 37,823.0 million
Market revenue in 2030USD 66,064.5 million
Growth rate8.3% (CAGR from 2023 to 2030)
Largest segmentAnti-vegf agents
Fastest growing segmentGene & Cell Therapy
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAnti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma, Gene & Cell Therapy

Other key industry trends

  • In terms of revenue, the North America accounted for 45.0% of the global ophthalmic drugs market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, U.S. is the fastest growing regional market and is projected to reach USD 25,551.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Ophthalmic Drugs Market Scope

Ophthalmic drugs market segmentation & scope
Anti-Allergy
Anti-VEGF agents
Non-steroidal drugs
Steroids
Anti-glaucoma
Gene & Cell Therapy
Others
Dry eye
Allergies
Glaucoma
Infection
Macular Degeneration
Diabetic Retinopathy
Others
Uveitis
Others
Topical
Subconjunctival
Intravitreal
Retrobulbar
Intracameral
Sytemic
Gels
Eye solutions & suspensions
Capsules & Tablets
Eye drops
Ointments

Ophthalmic Drugs Market Companies

Name Profile # Employees HQ Website

Global ophthalmic drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drugs market will help companies and investors design strategic landscapes.


anti-vegf agents was the largest segment with a revenue share of 32.71% in 2023. Horizon Databook has segmented the Global ophthalmic drugs market based on anti-allergy, anti-vegf agents, anti-inflammatory, anti-glaucoma, gene & cell therapy covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Ophthalmic Drugs Drug class Outlook (Revenue, USD Million, 2018-2030)
    • Anti-Allergy
    • Anti-VEGF agents
    • Anti-inflammatory
      • Non-steroidal drugs
      • Steroids
    • Anti-glaucoma
    • Gene & Cell Therapy
    • Others
  • Global Ophthalmic Drugs Disease Outlook (Revenue, USD Million, 2018-2030)
    • Dry eye
    • Allergies
    • Glaucoma
    • Infection
    • Retinal Disorders
      • Macular Degeneration
      • Diabetic Retinopathy
      • Others
    • Uveitis
    • Others
  • Global Ophthalmic Drugs Route of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Topical
    • Local Ocular
      • Subconjunctival
      • Intravitreal
      • Retrobulbar
      • Intracameral
    • Sytemic
  • Global Ophthalmic Drugs Dosage Type Outlook (Revenue, USD Million, 2018-2030)
    • Gels
    • Eye solutions & suspensions
    • Capsules & Tablets
    • Eye drops
    • Ointments

Reasons to subscribe to Global ophthalmic drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global ophthalmic drugs market databook

  • Our clientele includes a mix of ophthalmic drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global ophthalmic drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global ophthalmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global ophthalmic drugs market statistics, by regions, 2018-2030 (US$M)

Top 10 countries: Ophthalmic drugs market size, 2023 (USD Million)

Top 10 countries: Ophthalmic drugs market size, 2023 (USD Million)

Global ophthalmic drugs market, by region, 2023 (US$M)

Global ophthalmic drugs market statistics, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more